Rheumatoid arthritis: Anticytokine therapies on the horizon

被引：27

作者：

Koopman, WJ

Moreland, LW

机构：

[1] Univ Alabama Birmingham, Dept Med, Birmingham, AL 35294 USA

[2] Univ Alabama Birmingham, Div Clin Immunol & Rheumatol, Birmingham, AL 35294 USA

来源：

ANNALS OF INTERNAL MEDICINE | 1998年 / 128卷 / 03期

关键词：

D O I：

10.7326/0003-4819-128-3-199802010-00010

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：231 / 233

页数：3

共 21 条

[1] INTERLEUKIN-1 RECEPTOR ANTAGONIST - A NEW MEMBER OF THE INTERLEUKIN-1 FAMILY [J].

AREND, WP .

JOURNAL OF CLINICAL INVESTIGATION, 1991, 88 (05) :1445-1451

[2] INHIBITION OF THE PRODUCTION AND EFFECTS OF INTERLEUKIN-1 AND TUMOR-NECROSIS-FACTOR-ALPHA IN RHEUMATOID-ARTHRITIS [J].

AREND, WP ;

DAYER, JM .

ARTHRITIS AND RHEUMATISM, 1995, 38 (02) :151-160

[3]

Bresnihan B., 1996, Arthritis and Rheumatism, V39, pS73

[4] Dose-range and dose-frequency study of recombinant human interleukin-1 receptor antagonist in patients with rheumatoid arthritis [J].

Campion, GV ;

Lebsack, ME ;

Lookabaugh, J ;

Gordon, G ;

Catalano, M ;

Borenstein, D ;

Caldwell, J ;

Cohen, SA ;

Cohen, SB ;

Fleischmann, R ;

Heller, MD ;

Howard, P ;

Jaffer, AM ;

Kaine, JL ;

Kitsis, E ;

Kopp, EJ ;

Moreland, LW ;

OHanlan, M ;

Prupas, M ;

Rosenberg, A ;

Rutstein, J ;

Sack, MR ;

Schiff, MH ;

Singleton, CM ;

Taborn, J ;

Tindall, E ;

Weaver, AL ;

Yocum, D .

ARTHRITIS AND RHEUMATISM, 1996, 39 (07) :1092-1101

[5] Long-term protection against the effects of tumor necrosis factor by controlled delivery of the soluble p55 TNF receptor [J].

Eliaz, R ;

Wallach, D ;

Kost, J .

CYTOKINE, 1996, 8 (06) :482-487

[6] RANDOMIZED DOUBLE-BLIND COMPARISON OF CHIMERIC MONOCLONAL-ANTIBODY TO TUMOR-NECROSIS-FACTOR-ALPHA (CA2) VERSUS PLACEBO IN RHEUMATOID-ARTHRITIS [J].

ELLIOTT, MJ ;

MAINI, RN ;

FELDMANN, M ;

KALDEN, JR ;

ANTONI, C ;

SMOLEN, JS ;

LEEB, B ;

BREEDVELD, FC ;

MACFARLANE, JD ;

BIJL, H ;

WOODY, JN .

LANCET, 1994, 344 (8930) :1105-1110

[7] REPEATED THERAPY WITH MONOCLONAL-ANTIBODY TO TUMOR-NECROSIS-FACTOR-ALPHA (CA2) IN PATIENTS WITH RHEUMATOID-ARTHRITIS [J].

ELLIOTT, MJ ;

MAINI, RN ;

FELDMANN, M ;

LONGFOX, A ;

CHARLES, P ;

BIJL, H ;

WOODY, JN .

LANCET, 1994, 344 (8930) :1125-1127

[8]

ELLIOTT MJ, 1993, ARTHRITIS RHEUM, V21, P318

[9] Anticytokine treatment of established type II collagen-induced arthritis in DBA/1 mice - A comparative study using anti-TNF alpha, anti-IL-1 alpha/beta, and IL-1Ra [J].

Joosten, LAB ;

Helsen, MMA ;

vandeLoo, FAJ ;

vandenBerg, WB .

ARTHRITIS AND RHEUMATISM, 1996, 39 (05) :797-809

[10] TRANSGENIC MICE EXPRESSING HUMAN TUMOR-NECROSIS-FACTOR - A PREDICTIVE GENETIC MODEL OF ARTHRITIS [J].

KEFFER, J ;

PROBERT, L ;

CAZLARIS, H ;

GEORGOPOULOS, S ;

KASLARIS, E ;

KIOUSSIS, D ;

KOLLIAS, G .

EMBO JOURNAL, 1991, 10 (13) :4025-4031

← 1 2 3 →